{"Ticker": "DVA", "Company": "DaVita", "Sector": "Health Care", "Updated": "2023-08-07", "Rating": [{"Date": "2023-08-07", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Neutral to Buy", "Target_Change": "$100 to $142"}, {"Date": "2022-11-01", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$97 to $72"}, {"Date": "2022-10-31", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$117 to $74"}, {"Date": "2022-08-19", "Rating": "Resumed", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$106 to $117"}, {"Date": "2022-06-21", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Underperform", "Target_Change": "$110 to $90"}, {"Date": "2021-09-10", "Rating": "Initiated", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": "$145"}, {"Date": "2021-08-12", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$135 to $146"}, {"Date": "2021-03-26", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$127 to $118"}, {"Date": "2021-01-05", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$127"}, {"Date": "2020-01-24", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$72 to $97"}, {"Date": "2019-11-07", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2019-10-25", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2019-09-11", "Rating": "Downgrade", "Organization": "William Blair", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2019-07-26", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$70 to $65"}, {"Date": "2019-01-08", "Rating": "Upgrade", "Organization": "UBS", "Rating_Change": "Sell to Neutral", "Target_Change": ""}, {"Date": "2019-01-03", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$60"}, {"Date": "2018-12-14", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": ""}, {"Date": "2018-11-28", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": ""}, {"Date": "2018-11-16", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Sell", "Target_Change": "$64"}, {"Date": "2018-11-08", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Strong Buy to Mkt Perform", "Target_Change": ""}, {"Date": "2018-09-13", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Underweight to Neutral", "Target_Change": ""}, {"Date": "2018-01-04", "Rating": "Upgrade", "Organization": "BofA/Merrill", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2017-12-12", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$63 to $82"}, {"Date": "2017-12-11", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2017-12-07", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Strong Buy", "Target_Change": ""}]}